Liang; Gui-Bai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liang; Gui-Bai.The latest application filed is for "methods and compositions for treating idiopathic pulmonary fibrosis".

Company Profile

4.10.13

Liang; Gui-Bai - Scotch Plains NJ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and Compositions for Treating Idiopathic Pulmonary Fibrosis App 20210023079 - Liang; Gui-Bai	2021-01-28
Methods and Compositions for Treating Idiopathic Pulmonary Fibrosis App 20190282565 - LIANG; Gui-Bai	2019-09-19
Novel Tricyclic Calcium Sensing Receptor Antogonists For The Treatment Of Osteopososis App 20160311791 - Liang; Gui-Bai ; et al.	2016-10-27
Substituted bicyclic amines for the treatment of diabetes Grant 8,759,539 - He , et al. June 24, 2	2014-06-24
Antidiabetic tricyclic compounds Grant 8,399,507 - Liang , et al. March 19, 2	2013-03-19
Substituted Spirocyclic Amines Useful As Antidiabetic Compounds App 20120041012 - Aster; Susan D. ; et al.	2012-02-16
Substituted Bicyclic Amines For The Treatment Of Diabetes App 20110207737 - He; Jiafang ; et al.	2011-08-25
Antidiabetic Tricyclic Compounds App 20100216694 - Liang; Gui-Bai ; et al.	2010-08-26
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,560,455 - Biftu , et al. July 14, 2	2009-07-14
Antidiabetic bicyclic compounds Grant 7,442,808 - Ge , et al. October 28, 2	2008-10-28
Antidiabetic bicyclic compounds App 20070265332 - Ge; Min ; et al.	2007-11-15
Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,259,160 - Liang , et al. August 21, 2	2007-08-21
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Grant 7,196,095 - Biftu , et al. March 27, 2	2007-03-27
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060258646 - Biftu; Tesfaye ; et al.	2006-11-16
Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes App 20060211682 - Liang; Gui-Bai ; et al.	2006-09-21
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,101,871 - Biftu , et al. September 5, 2	2006-09-05
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20040254167 - Biftu, Tesfaye ; et al.	2004-12-16
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds App 20040176396 - Biftu, Tesfaye ; et al.	2004-09-09
Oxadiazole benzenesulfonamides as selective .beta..sub.3 Agonist for the treatment of Diabetes and Obesity Grant 6,034,106 - Biftu , et al. March 7, 2	2000-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.